Phase 2 Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 18 and 80 years old (inclusive)
- People who have been diagnosed with pulmonary hypertension (high blood pressure in the lungs) through a procedure called a right heart catheterisation, at any point before the screening visit
- People whose pulmonary hypertension is classified as WHO Functional Class II or III, meaning symptoms affect daily activities to a mild or moderate degree
- People who already have a CardioMEMS PA Sensor device implanted (a small device that monitors pressure in the lungs)
Who may not be able to join:
- People who were admitted to hospital for pulmonary hypertension within the 3 months before screening
- People who had a major surgical procedure within the 3 months before screening, unless the trial doctor has assessed them as fully recovered
- People whose pulmonary hypertension was caused by HIV, portal hypertension (high blood pressure in the liver), schistosomiasis (a parasitic infection), or an uncorrected heart defect present from birth
- People with a history of left-sided heart disease or other significant heart conditions
- People with a history of high blood pressure that has not been well controlled
- People with significantly reduced kidney function (based on a kidney function measurement called eGFR being 30 or below — confirm with trial site)
- People whose life expectancy is estimated to be less than 12 months, as assessed by the trial doctor
- People who have been diagnosed with cancer within the 5 years before joining the trial
- People for whom MRI scans or other required testing methods are not medically suitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 781-479-2267
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.